Alcidion Group Limited (ASX:ALC) Surges 33% Yet Its Low P/S Is No Reason For Excitement

Alcidion Group Limited (ASX:ALC) shares have continued their recent momentum with a 33% gain in the last month alone. The annual gain comes to 122% following the latest surge, making investors sit up and take notice. Even after such a large jump in price, Alcidion Group may still look like a strong buying opportunity at present with its price-to-sales (or "P/S") ratio of 4.6x, considering almost half of all companies in the Healthcare Services industry in Australia have P/S ratios greater than 15.3x and even P/S higher than 184x aren't out of the ordinary. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's so limited. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Check out our latest analysis for Alcidion Group ASX:ALC Price to Sales Ratio vs Industry January 14th 2026 How Alcidion Group Has Been Performing Alcidion Group could be doing better as it's been growing revenue less than most other companies lately. The P/S ratio is probably low because investors think this lacklustre revenue performance isn't going to get any better. If you still like the company, you'd be hoping revenue doesn't get any worse and that you could pick up some stock while it's out of favour. Want the full picture on analyst estimates for the company? Then our free report on Alcidion Group will help you uncover what's on the horizon. What Are Revenue Growth Metrics Telling Us About The Low P/S? The only time you'd be truly comfortable seeing a P/S as depressed as Alcidion Group's is when the company's growth is on track to lag the industry decidedly. If we review the last year of revenue growth, the company posted a worthy increase of 10%. The latest three year period has also seen a 19% overall rise in revenue, aided somewhat by its short-term performance. So we can start by confirming that the company has actually done a good job of growing revenue over that time. Shifting to the future, estimates from the three analysts covering the company suggest revenue should grow by 11% per annum over the next three years. That's shaping up to be materially lower than the 223% per year growth forecast for the broader industry. With this in consideration, its clear as to why Alcidion Group's P/S is falling short industry peers. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock. What We Can Learn From Alcidion Group's P/S? Even after such a strong price move, Alcidion Group's P/S still trails the rest of the industry. Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company. We've established that Alcidion Group maintains its low P/S on the weakness of its forecast growth being lower than the wider industry, as expected. Right now shareholders are accepting the low P/S as they concede future revenue probably won't provide any pleasant surprises. It's hard to see the share price rising strongly in the near future under these circumstances. You should always think about risks. Case in point, we've spotted 1 warning sign for Alcidion Group you should be aware of. It's important to make sure you look for a great company, not just the first idea you come across. So if growing profitability aligns with your idea of a great company, take a peek at this free list of interesting companies with strong recent earnings growth (and a low P/E).